- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02004145
Trial of a Positive Psychology Intervention in Major Depressive Disorder (HOPE)
Trial of a Positive Psychology Intervention to Reduce Suicide Risk in Patients With Major Depression
In this study, the investigators will perform an exploratory randomized trial of Positive Psychology (PP). The trial will consist of 50 participants and will compare the impact of a phone-based PP intervention vs. an attentional control condition, in Major Depressive Disorder (MDD) patients who are hospitalized for SI or following a suicide attempt. This is a 12 week trial with 6 weeks of intervention and two blinded follow-up assessments at 6 and 12 weeks.
Specific Aim #1: To assess the feasibility and acceptability of the phone-based PP intervention in this high-risk population.
Hypotheses: The intervention will be feasible (with most patients completing at least 4/6 PP and with follow-up data from at least 80% of subjects). The ratings of ease and subjective helpfulness of the exercise and other mental states as measured before and after each PP exercise will be more than 6 out of 10 and higher than the same ratings obtained from subjects in the control condition.
Specific Aim #2: To examine the impact of the six-session PP intervention on positive psychological well-being.
Hypothesis: Compared to control subjects, subjects randomized to PP will have greater scores on scales of optimism (measured via the Life Orientation Test-Revised [LOT-R]), gratitude (Gratitude Questionnaire-6 [GQ-6]), and positive affect (Positive Affect Negative Affect Schedule [PANAS]) at 6 and 12 weeks.
Specific Aim #3 (primary aim): To assess the impact of the PP intervention on key suicide risk factors.
Hypothesis: PP subjects will have greater scores on scales of hopelessness (Beck Hopelessness Scale [BHS]; primary study outcome measure), suicidal ideation (SI) (Concise Health Risk Tracking scale [CHRT]), and depression (Quick Inventory of Depressive Symptomatology-Self Report [QIDS-SR]) at 6 and 12 weeks.
We will also measure impact on readmission and suicide attempts to assess these key outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be randomized to receive the intervention or recollection (control) arm. They will be randomized by a random-number generator and will be assigned a condition after receiving baseline questionnaires. The RA/blinded assessor will be blind to the study condition. The interventionist and subjects will not be blind to the study condition.
Baseline assessments: After consent and eligibility rule outs, subjects will receive baseline questionnaires to assess hopelessness (BHS46), suicidality (CHRT47), depression (QIDS-SR48), and positive states (LOT-R,43 GQ-6,44 PANAS45). Then, subjects will be randomized via random number generator to receive the control or intervention condition.
After completing baseline questionnaires and receiving randomization, subjects in both groups will have a 20 minute initial in-hospital session ("week #1"), within a week of anticipated discharge, in which the interventionist will provide a treatment manual specific to their condition, review the rationale for the initial exercise, and assign the exercise. The next day, the exercise will be reviewed and an exercise assigned for the next week. Immediately after completing the exercise, subjects will rate (on a Likert scale of 1-5) ease of exercise completion, overall utility, and initial impact on hopelessness/optimism, to assess immediate effects.
After discharge from the hospital, subjects will have five 20 minute weekly phone sessions ("weeks #2-6") with a different exercise used each week (assigned in the same order to all subjects). The phone sessions will include: (a) review of the prior week's exercise (including subject ratings of ease and impact as in week #1), (b) discussion of the rationale and assignment of the next week's exercise via a guided review of the study manual, and (c) completion of the Clinical Status questions and the Clinical Global Improvement scale (CGI) to monitor symptoms and improvement. Sessions will be audiotaped and random sessions reviewed by our PP consultant to ensure fidelity to the intervention (and that other techniques, e.g., Cognitive Behavioral Therapy, are not used).
Positive psychology (intervention condition)
Exercises. These were selected based on their superior performance in our pre-pilot study and others' work:
- Gratitude for positive events: Subjects recall three events, small or large, in the preceding week that were associated with satisfaction, happiness, pride, or other positive states.
- Gratitude letter: Subjects write a letter of gratitude thanking a person for an act of kindness; subject may, at their discretion, share the letter with the other person.
- Performing acts of kindness: Subjects are instructed to complete three acts of kindness in one day. The acts can be small or large, planned or spontaneous, but must be expressly completed to be kind to another.
- Using personal strengths: Subjects undergo a brief assessment of personal strengths, then find a new way to use that strength in the next 24 hours.
- Enjoyable and meaningful activities: Subjects complete a series of self-selected activities that vary between those that bring immediate boosts in mood and those that are more deeply meaningful.
- Repetition of an exercise previously done.
Recollection (control condition) The recollection condition was selected because it has been used in a prior study by our team of a phone-based positive psychology intervention and it was found to be feasible and well-accepted. Each week, subjects will record recent life events in a manual without describing emotions associated with the events. The nature, setting, or type of events to be recorded will differ each week to provide variety and maintain subjects' interest. This will be described as an intervention that may assist with organization and hone recall of important life events. Also, as an attentional control, it has a parallel structure to the experimental arm with a treatment manual, weekly exercises, and weekly calls to review exercises.
Follow-up 6 and 12 week phone call. After completion of the intervention (6 weeks), and then at 12 weeks, a blinded study research assistant (RA) will call subjects at 6 and 12 weeks to repeat measures of hopelessness (BHS), suicidality (CHRT), depression (QIDS-SR) and positive states (e.g., GQ-6, PANAS, LOT-R). Subjects will also be asked to rate their overall satisfaction with the treatment they received for their cardiac condition (outside of this study) over the last 6 and 12 weeks on a scale of 1 (excellent) to 5 (poor). We will record specific times that subjects would prefer to be called (and not to be called) for future follow-ups, to reduce intrusion on subjects' lives. We will also send a postcard to subjects reminding them of their upcoming study phone call. The blinded assessor will make 2 follow-up phone calls (at 6 and 12 weeks) to gather information about outcomes. If subjects would rather complete the questions in written form rather than over the phone, we will send them a written packet at the time of each follow-up.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient admitted to Massachusetts General Hospital inpatient psychiatric unit
- Age 18 and older
- Able to read/write in English
- SI documented on admission OR admission due to a suicide attempt
- Admission diagnosis of MDD (and current major depressive episode), confirmed using the Mini International Neuropsychiatric Interview (MINI) and inpatient chart review
Exclusion Criteria:
- Psychotic symptoms, as assessed using the MINI and inpatient chart review
- Cognitive disorder, assessed using a six-item cognitive screen developed for research
- Primary admission diagnosis of substance use disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Positive Psychology
The Positive Psychology intervention consists of 6 exercises that will be completed by the participant with the guidance of a trainer. Exercises: Gratitude for positive events Gratitude letter Performing acts of kindness Using personal strengths Enjoyable and meaningful activities: Repeating one of the previous exercises. |
The Positive Psychology intervention consists of 6 exercises that will be completed by the participant with the guidance of a trainer.
|
|
Sham Comparator: Organizational Skills
The Control Condition consists of 6 exercises that will be completed by the participant with the guidance of a trainer. Exercises: Daily Events Health Events Morning and Evening Events Interactions with Others Leisure Time Activities Repeating one of the previous exercises. |
The Control Condition consists of 6 exercises that will be completed by the participant with the guidance of a trainer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in BHS Scores
Time Frame: Baseline, 6 weeks, and 12 weeks
|
The Beck Hopelessness Scale (BHS) is a validated, twenty item, self-report measure that assesses three major aspects of hopelessness: feelings about the future, loss of motivation, and expectations.
|
Baseline, 6 weeks, and 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in CHRT Scores
Time Frame: Baseline, 6 weeks, and 12 weeks
|
The Concise Health Risk Tracking scale (CHRT) is a brief, twelve item, self-report and clinician rating of suicidal risk.
|
Baseline, 6 weeks, and 12 weeks
|
|
Change in QIDS-SR Scores
Time Frame: Baseline, 6 weeks, and 12 weeks
|
The Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR) is a sixteen item, self-report measure of depressive symptom severity derived from the 30-item Inventory of Depressive Symptomatology (IDS).
|
Baseline, 6 weeks, and 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in LOT-R Scores
Time Frame: Baseline, 6 weeks, and 12 weeks
|
The Life Orientation Test-Revised (LOT-R) is a validated, six item, self-report measure of optimism.
|
Baseline, 6 weeks, and 12 weeks
|
|
Change in GQ-6 Scores
Time Frame: Baseline, 6 weeks, and 12 weeks
|
The Gratitude Questionnaire 6 is a brief, validated six-item measure of dispositional gratitude.
|
Baseline, 6 weeks, and 12 weeks
|
|
Change in PANAS Scores
Time Frame: Baseline, 6 weeks, and 12 weeks
|
The Positive Affect Negative Affect Schedule (PANAS) consists of ten words that subjects rate on a 5-point likert scale to asses positive affect.
|
Baseline, 6 weeks, and 12 weeks
|
|
Ease of Exercises
Time Frame: Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
|
Ease of exercises will be measured by a self-report 10-point Likert scale (0=very difficult to complete, 10=very easy to complete).
Ease will be defined as an average score of 6 or more on this scale.
|
Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
|
|
Rate of Intervention Feasibility
Time Frame: 12 weeks
|
Rate of intervention feasibility will be measured by the number of exercises and follow-up assessments completed by each subject.
There are 6 exercises and 2 follow-up assessments in total .
A good rate of completion will be defined as an average of 4 or more exercises completed and >80% of follow-up assessments completed per subject.
|
12 weeks
|
|
Immediate Impact of Exercises
Time Frame: Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
|
Immediate impact of exercises will be measured by three self-report 10-point Likert scales measuring hopelessness (0=not hopeless, 10=very hopeless), mental organization (0=not organized, 10=very organized), and optimism (0=not optimistic, 10=very optimistic).
Immediate impact will be defined as an average score of 6 or more on these scales.
|
Week 1, Week 2, Week 3, Week 4, Week 5, Week 6
|
|
Readmissions
Time Frame: 12 weeks
|
Number of readmissions to the hospital
|
12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013P001234
- SRG-2-019-12 (Other Grant/Funding Number: AFSP)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
Gang WangWest China Hospital; The First Hospital of Hebei Medical University; Tianjin... and other collaboratorsRecruitingMajor Depressive Disorder (MDD) | Depression - Major Depressive DisorderChina
-
Brian MickeyNational Institute of Mental Health (NIMH)RecruitingMajor Depressive Episode | Depression - Major Depressive Disorder | Treatment-Resistant Major Depressive DisorderUnited States
-
Second Affiliated Hospital of Tsinghua UniversityNot yet recruiting
-
First People's Hospital of HangzhouNot yet recruitingMajor Depressive Disorder
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Recruiting
-
Shandong Provincial HospitalShandong UniversityRecruiting
-
Engrail Therapeutics INCCompletedMajor Depressive DisorderUnited Kingdom
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Aalborg University HospitalRecruitingDepressive Disorder | Depression | Depressive Episode | Depressive Disorders | Depressive Episodes | Depression - Major Depressive Disorder | Depressive Disorder, Major Depressive DisorderDenmark
-
Unity Health TorontoUniversity of Toronto; Toronto Metropolitan UniversityRecruitingMajor Depressive Disorder (MDD) | Major Depressive Episode | Treatment-Resistant Major Depressive DisorderCanada
Clinical Trials on Positive Psychology
-
Brigham and Women's HospitalCompletedMultiple SclerosisUnited States
-
Assuta Ashdod HospitalNot yet recruitingPain | Anxiety | Virtual Reality
-
Swiss Paraplegic Research, NottwilCompletedChronic Pain | Spinal Cord InjurySwitzerland
-
Massachusetts General HospitalCompletedType 2 DiabetesUnited States
-
Brigham and Women's HospitalMassachusetts General Hospital; Consortium of Multiple Sclerosis CentersCompletedMultiple SclerosisUnited States
-
The Hong Kong Polytechnic UniversityRecruitingAdolescent DevelopmentHong Kong
-
Brigham and Women's HospitalNational Cancer Institute (NCI)CompletedHematopoietic/Lymphoid Cancer | Hematologic Malignancy | Blood CancerUnited States
-
Brigham and Women's HospitalCompletedHematologic Malignancy | CaregiverUnited States
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Coronary SyndromeUnited States
-
Massachusetts General HospitalCompletedSuicidal Ideation | Suicide AttemptUnited States